Bone Marrow, Hematologic
Conditions
Keywords
Quantitative Marrow Imaging, Marrow Reserve, Radiotherapy
Brief summary
To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.
Interventions
OTHERdata collection
The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders. * Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives. * Ability to provide informed consent for prospective participation, when applicable.
Exclusion criteria
Participants meeting any of the following criteria will be excluded: * Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation. * Insufficient clinical information available to support study objectives. * Pregnant women
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety and adverse events (AEs). | Through study completion; an average of 1 year. | Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Countries
United States
Contacts
CONTACTOmran Saifi, MD
PRINCIPAL_INVESTIGATOROmran Saifi, MD
UT MD Anderson Cancer Center
Outcome results
None listed